Shinhan Investment Corp., KTB Growth Industry Hedge Fund, KTB Mezzanine Private Investment Trust No. 73 and KTB Mezzanine Private Investment Trust No. 74 funds managed by KTB Asset Management Co., Ltd acquired 3.92% in Km Pharmaceutical Co., Ltd. from Mun, Sung Keun for KRW 2 billion.
May 22, 2017
Share
Shinhan Investment Corp., KTB Growth Industry Hedge Fund, KTB Mezzanine Private Investment Trust No. 73 and KTB Mezzanine Private Investment Trust No. 74 funds managed by KTB Asset Management Co., Ltd acquired 3.92% in Km Pharmaceutical Co., Ltd. (XKON:A237720) from Mun, Sung Keun for KRW 2 billion on May 18, 2017. As reported, Shinhan Investment Corp. acquired 0.04 million shares, KTB Growth Industry Hedge Fund acquired 0.02 million shares and KTB Mezzanine Private Investment Trust No. 73 and KTB Mezzanine Private Investment Trust No. 74 collectively acquired 0.02 million shares at KRW 22,600 per share.
Shinhan Investment Corp., KTB Growth Industry Hedge Fund, KTB Mezzanine Private Investment Trust No. 73 and KTB Mezzanine Private Investment Trust No. 74 funds managed by KTB Asset Management Co., Ltd completed the acquisition of 3.92% in Km Pharmaceutical Co., Ltd. (XKON:A237720) from Mun, Sung Keun on May 18, 2017.
KMPHARMACEUTICAL Co.,Ltd., formerly IBKS No.3 Special Purpose Acquisition Company, is a Korea-based company mainly engaged in the manufacturing and distribution of oral hygiene products and cosmetics. Oral hygiene products include toothpaste, toothbrush and goggles. Cosmetic products consist of shampoo, body wash, sun cream, moisturizing cream, as well as lip balm and others. The company distributes its products within domestic market and to overseas markets including North America, South America, Europe, China, Malaysia, Singapore, Vietnam and Australia.
KMPHARMACEUTICAL CO.,LTD. 
